β-Nicotinamide Mononucleotide (NMN) is a naturally occurring key metabolite and the direct precursor to NAD+. It is converted in a single enzymatic step by intracellular NMNAT, representing the shortest and most efficient pathway to elevate cellular NAD+ levels.
Brought to prominence by Harvard's David Sinclair and colleagues, NMN has become the most popular NAD+ precursor in the anti-aging and longevity market. A landmark 2026 Nature Metabolism study confirmed that 1 g/day NMN doubles whole-blood NAD+ in healthy adults.
NMN has reasonable intrinsic oral absorption through specific small-intestinal transporters. However, liposomal encapsulation takes NMN performance to the next level—amplifying bioavailability, improving stability, and unlocking differentiated formulation routes.
With liposomal delivery, NMN achieves three key advantages:
A phospholipid bilayer vesicle engineered at nanoscale to protect NMN and enhance cellular uptake for rapid NAD+ conversion.
Non-GMO sunflower lecithin
Double-layer membrane mimicking natural cell structure. Hydrophilic heads face outward and inward; hydrophobic tails form the core barrier.
Acid-resistant protection
The lipid tail core blocks gastric acid, enzymes, and oxidation. NMN stays intact through stomach transit — no degradation to nicotinamide.
≥98% purity active payload
Water-soluble NMN encapsulated in the inner aqueous compartment. Protected from the external environment until membrane fusion releases it intracellularly.
Enhanced cellular uptake
Liposome bilayer fuses with cell membrane, releasing NMN directly into the cytoplasm. NMN is then rapidly converted to NAD+ via the NRK pathway — boosting intracellular NAD+ levels efficiently.
Five-stage GMP manufacturing process ensuring uniform particle size and high encapsulation efficiency.
Phospholipids dissolved in organic solvent, dried to a thin film under vacuum. NMN aqueous solution added for hydration.
Probe sonication breaks down multi-lamellar vesicles into uniform small unilamellar vesicles (SUVs), 80-200 nm.
High-pressure homogenization at 20,000 psi ensures narrow particle size distribution (PDI < 0.2) and stability.
Sterile filtration (0.22 µm), encapsulation efficiency testing (≥92%), particle size verification, and microbial screening.
Freeze-drying for powder format or aseptic filling for liquid. Full COA issued with every batch.
Research-backed benefits of NMN supplementation supported by clinical evidence.
Elevates NAD+ levels and activates sirtuin longevity proteins across multiple tissues.
Supports mitochondrial function and ATP production for sustained daily vitality.
Improves insulin sensitivity and supports healthy glucose metabolism.
Anti-aging ingredient for topical cosmeceutical and skincare formulations.
NMN is increasingly recognized as a dual-route anti-aging ingredient—delivering benefits through both oral supplementation and topical application. Liposomal delivery is the key enabler for the topical route, solving NMN's stability and transdermal penetration challenges.
When paired with NAD+, peptides, or other cosmeceutical actives, liposomal NMN enables a “cellular-level anti-aging” skincare positioning. Recommended usage: 1–5% NMN in serum or cream formulations.
Ideal for: Anti-aging serums, day/night creams, eye treatments, and sheet masks.
Evidence-based guidance for NMN product development and regulatory compliance.
| Route | Typical Dosage | Notes |
|---|---|---|
| Oral | 250–500 mg/day | Multinational trials; Nature used 1 g/day |
| Sublingual / TD | Per label | Liposomal for faster absorption |
No unified regulatory dosage. Above ranges reflect common supplement intervals. Not medical advice.
Common questions about liposomal NMN.
Request samples, review our technical documentation, or speak with a formulation specialist about integrating liposomal NAD+ into your product line.